Our finding of GAD67 in regulating AD pathology is also supported by earlier studies demonstrating a strong link between gamma oscillation activity (20–80 Hz) and AD [5, 42] as well as tonic GABA inhibition [44, 45]. This evidence concerns the gene GAD1 and Alzheimer disease.